CAR-T cells (Figure 3), specifically targeting the epidermal growth factor receptor, can be employed in the treatment of advanced cholangiocarcinoma cases (102).CD133, a recognized cancer stem cell marker, is highly expressed and linked with cancer progression. Here, PROM1 is linked to cancer.